Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of enzyme replacement therapy on linear growth in Korean patients with mucopolysaccharidosis type II (Hunter syndrome).

Journal of Korean medical science - 1 Feb 2014

Cho Sung Yoon, Huh Rimm, Chang Mi Sun, Lee Jieun, Kwun Younghee, Maeng Se Hyun, Kim Su Jin, Sohn Young Bae, Park Sung Won, Kwon Eun-Kyung, Han Sun Ju, Jung Jooyoun, Jin Dong-Kyu

Abstract excerpt

Hunter syndrome (or mucopolysaccharidosis type II [MPS II]) arises because of a deficiency in the lysosomal enzyme iduronate-2-sulfatase. Short stature is a prominent and consistent feature in MPS II. Enzyme replacement therapy (ERT) with idursulfase (Elaprase®) or idursulfase beta (Hunterase®) have been developed for these patients. The effect of ERT on the growth of Korean patients with Hunter syndrome was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Body Height
Share to Cognitive Dysfunction

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Demography

Share to Enzyme Replacement Therapy

Share to Iduronate Sulfatase

Share to Mucopolysaccharidosis II

Share to Protein Isoforms

Share to Republic of Korea

Source

Open in PubMed Open full text

Identifiers

PMID: 24550654
DOI: 10.3346/jkms.2014.29.2.254
PMCID: PMC3924006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of enzyme replacement therapy on linear growth in Korean patients with mucopolysaccharidosis type II (Hunter syndrome).PMID 24550654Read ↗

The natural history of growth in patients with Hunter syndrome: Data from the Hunter Outcome Survey (HOS).Semantic proximity Read ↗

A Case Report of a Japanese Boy with Morquio A Syndrome: Effects of Enzyme Replacement Therapy Initiated at the Age of 24 Months.Semantic proximity Read ↗

Long-term impact of early initiation of enzyme replacement therapy in 34 MPS VI patients: A resurvey study.Semantic proximity Read ↗

Activities of daily living in patients with Hunter syndrome: impact of enzyme replacement therapy and hematopoietic stem cell transplantation.Semantic proximity Read ↗

A Novel Y-Shaped Pegylated Recombinant Human Growth Hormone for Children With Growth Hormone DeficiencySemantic proximity Read ↗

Impact of ERT and Follow up of 17 Patients from the Same Family with Mild form of MPS IISemantic proximity Read ↗

Effects of idursulfase enzyme replacement therapy for Mucopolysaccharidosis type II when started in early infancy: comparison in two siblings.Semantic proximity Read ↗

Height outcome of the recombinant human growth hormone treatment in patients with SHOX gene haploinsufficiency: a meta-analysis.Semantic proximity Read ↗

Evaluation of ADL in patients with Hunter disease using FIM score.Semantic proximity Read ↗

Growth hormone therapy in achondroplasia.Semantic proximity Read ↗

Delayed growth and puberty in patients with Gaucher disease type 1: natural history and effect of splenectomy and/or enzyme replacement therapy.Semantic proximity Read ↗

Genetics and Gene Therapy in Hunter Disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.